Effects of DPYD, GSTP1, and MTHFR polymorphisms on clinical outcome of patients
 with advanced colorectal cancer treated with 5-FU-based chemotherapy

ZHANG Jie; LI Changhai; LI Linzi; WANG Qin; FANG Gong; XIE Xiongwei; WEI Zhidan; ZHANG Yong; LIAO Qiuxia

doi:10.3969/j.issn.1002-266X.2020.10.003

Home>Articles>Effects of DPYD, GSTP1, and MTHFR polymorphisms on clinical outcome of patients with advanced colorectal cancer treated with 5-FU-based chemotherapy

DOI: 10.3969/j.issn.1002-266X.2020.10.003

Effects of DPYD, GSTP1, and MTHFR polymorphisms on clinical outcome of patients with advanced colorectal cancer treated with 5-FU-based chemotherapy

ZHANG Jie

LI Changhai

LI Linzi

WANG Qin

FANG Gong

XIE Xiongwei

WEI Zhidan

ZHANG Yong

LIAO Qiuxia

Machine-generated Keywords：

Publication Date：2020-04-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 9-12,36 )

Shandong Medical Journal

PKUISTIC

ISSN：1002-266X

Year, Vol.(Issue)：2020,60(10)